The Latest in Schizophrenia & Other Psychotic Disorders

Clinical Psychiatry News

Novel drug offers rapid relief from agitation in serious mental illness

May 7, 2021

Clinical Psychiatry News

The cloudy role of cannabis as a neuropsychiatric treatment

May 3, 2021

Current Psychiatry

10 devastating consequences of psychotic relapses

May 3, 2021

Schizophrenia & Other Psychotic Disorders

Clinical Psychiatry News

Nonpharma approach a potential ‘game changer’ in schizophrenia?

April 30, 2021

Schizophrenia & Other Psychotic Disorders

Clinical Psychiatry News

Potential first-in-class schizophrenia drug cuts negative symptoms

April 29, 2021

Schizophrenia & Other Psychotic Disorders

Clinical Psychiatry News

Are psychiatric disorders a ‘canary in a coal mine’ for Alzheimer’s disease?

April 27, 2021

Clinical Psychiatry News

Cortical surface changes linked to sensorimotor abnormalities in schizophrenia

April 20, 2021

Clinical Psychiatry News

Antipsychotics protective against COVID-19?

April 16, 2021

Clinical Psychiatry News

Contradictions abound in ‘The End of Mental Illness’

April 9, 2021

Current Psychiatry

Steroid-induced psychiatric symptoms: What you need to know

April 1, 2021

Current Psychiatry

High-dose lumateperone: A case report

April 1, 2021

Schizophrenia & Other Psychotic Disorders

Current Psychiatry

Switching antipsychotics: A guide to dose equivalents

April 1, 2021

Schizophrenia & Other Psychotic Disorders

Clinical Psychiatry News

Discovery of schizophrenia gene could advance research, therapies

March 25, 2021

Schizophrenia & Other Psychotic Disorders

Clinical Psychiatry News

Blood pressure meds tied to increased schizophrenia risk

March 22, 2021

Clinical Psychiatry News

‘Landmark’ schizophrenia drug in the wings?

March 3, 2021

Schizophrenia & Other Psychotic Disorders